Delivering Significant Value to Shareholders

The Board of Directors and the Management Team at Ziopharm are committed to implementing the Company’s strategy and to delivering significant value to its shareholders. We remain driven by our goal of developing technologies to help as many patients as possible. We have worked to put Ziopharm in what we believe to be a strong financial position to weather the ongoing COVID-19 pandemic and ensure visibility into key clinical data outputs in each of our programs.